FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily InjectionsFDA approves Sanofi's Qfitlia for hemophilia, offering bimonthly injections and significant bleeding reduction at $642K annually.
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda RolloutMerck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Want to Avoid Depression? Try GLP-1 Medications, Citrus, and ExerciseA study shows Mounjaro and Zepbound aid weight loss in non-diabetic individuals, with participants losing an average of 13% body weight.
Tesla’s Driverless Robotaxi Service Set to Launch in June: Will Musk’s Promise Finally Be Realized?Tesla's driverless robotaxi service launches in June in Austin, aiming to reshape autonomous driving despite safety concerns.
FDA Apporoves 'Alhemo' to Help Hemophilia Patients Manage BleedingNovo Nordisk's hemophilia treatment Alhemo has FDA approval, targeting patients with antibodies against traditional therapies.
Voters Demand Change: Why 2024 Is the Year World Leaders Are Losing Approval FastVoter dissatisfaction is rising, with approval ratings for leaders in advanced economies plummeting, signaling potential leadership changes.
Yoon’s Approval Rating Crashes: Approval Falls to 17.3%, Disapproval Rises to 79.2%South Korean President Yoon Suk Yeol's approval rating plummets to 17.3% after martial law declaration, with rising disapproval.
US Approves $3.5 Billion Sale of Apache Helicopters to South KoreaThe US State Department approved a $3.5 billion sale of 36 Apache helicopters to South Korea, enhancing regional security.
Novo Nordisk’s Wegovy Approved in UK for Reducing Cardiovascular Risk in Obese AdultsNovo Nordisk recently announced that its weight-loss drug, Wegovy, has been approved by UK regulatory authorities for use...
Taiwanese President Loses Nearly 2 Million Supporters in Record TimeTaiwan's President, Lai Ching-te, has experienced a significant drop in his approval rating, falling by 9.8% in just a month.
FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections FDA approves Sanofi's Qfitlia for hemophilia, offering bimonthly injections and significant bleeding reduction at $642K annually.
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout Merck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Want to Avoid Depression? Try GLP-1 Medications, Citrus, and Exercise A study shows Mounjaro and Zepbound aid weight loss in non-diabetic individuals, with participants losing an average of 13% body weight.
Tesla’s Driverless Robotaxi Service Set to Launch in June: Will Musk’s Promise Finally Be Realized? Tesla's driverless robotaxi service launches in June in Austin, aiming to reshape autonomous driving despite safety concerns.
FDA Apporoves 'Alhemo' to Help Hemophilia Patients Manage Bleeding Novo Nordisk's hemophilia treatment Alhemo has FDA approval, targeting patients with antibodies against traditional therapies.
Voters Demand Change: Why 2024 Is the Year World Leaders Are Losing Approval Fast Voter dissatisfaction is rising, with approval ratings for leaders in advanced economies plummeting, signaling potential leadership changes.
Yoon’s Approval Rating Crashes: Approval Falls to 17.3%, Disapproval Rises to 79.2% South Korean President Yoon Suk Yeol's approval rating plummets to 17.3% after martial law declaration, with rising disapproval.
US Approves $3.5 Billion Sale of Apache Helicopters to South Korea The US State Department approved a $3.5 billion sale of 36 Apache helicopters to South Korea, enhancing regional security.
Novo Nordisk’s Wegovy Approved in UK for Reducing Cardiovascular Risk in Obese Adults Novo Nordisk recently announced that its weight-loss drug, Wegovy, has been approved by UK regulatory authorities for use...
Taiwanese President Loses Nearly 2 Million Supporters in Record Time Taiwan's President, Lai Ching-te, has experienced a significant drop in his approval rating, falling by 9.8% in just a month.
Hot Topics